Trial Profile
A phase II trial of ASP 3662 in patients with agitation associated with Alzheimer's disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs ASP 3662 (Primary)
- Indications Agitation; Alzheimer's disease
- Focus Therapeutic Use
- 14 Feb 2017 New trial record